OpenQase - Quantum Computing Business Applications Platform
BETA
Case StudiesRelated ContentBlog
Sign InGet Started
  • About OpenQase
  • Roadmap
  • Contact Us
  • Blog
  • Case Studies
  • Related Content
  • GitHub(opens in new tab)
  • Threads(opens in new tab)
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
OpenQase - Quantum Computing Business Applications Platform

© 2026 OpenQase. All rights reserved.

Built with ❤️ by the quantum computing community

    Back to Industries

    Pharmaceutical

    Applications of quantum computing in drug discovery, molecular modeling, and pharmaceutical development processes.

    11 Case Studies
    8 Target Roles

    The pharmaceutical industry faces significant computational challenges throughout the drug development lifecycle, from initial discovery to manufacturing and distribution. Quantum computing offers potential solutions to these challenges through several key applications that address fundamental computational bottlenecks in the sector.

    Molecular simulation represents the most promising near-term application, where quantum algorithms can model electron behavior and molecular interactions with greater accuracy than classical methods. This capability enables more precise binding affinity predictions, conformational analysis, and reaction mechanism modeling. Enhanced simulation accuracy directly impacts candidate selection and optimization, potentially reducing costly late-stage failures that plague traditional drug development.

    Drug discovery applications extend beyond individual molecular simulations to encompass high-throughput virtual screening against biological targets. Quantum approaches may enable screening of larger chemical spaces while maintaining higher prediction accuracy, expanding the universe of potential therapeutic compounds. Several pharmaceutical companies have established quantum research initiatives specifically targeting these capabilities.

    Protein folding and structure prediction represent computationally intensive processes critical to understanding biological targets. Quantum algorithms show promise for modeling the complex energy landscapes that determine protein structures, potentially accelerating structure determination for novel targets and enabling more accurate predictions for proteins resistant to conventional methods.

    Clinical trial optimization applications leverage quantum computing to address complex patient stratification problems, treatment assignment optimization, and trial protocol design. These capabilities may improve trial success rates while reducing time and resource requirements—addressing a critical bottleneck in the development process.

    Manufacturing process optimization applications include production scheduling, resource allocation, and quality control—problems with numerous constraints and objectives that quantum algorithms may address more effectively than classical approaches.

    Implementation strategies for pharmaceutical organisations should focus on identifying specific computational bottlenecks in current development processes, establishing partnerships with quantum technology providers, and developing hybrid approaches that can deliver incremental benefits as quantum hardware matures.


    Related Case Studies

    D-Wave and NEC partner for applications in Japan

    A strategic partnership in Japan to deploy quantum annealing solutions for optimizing manufacturing, logistics, and financial services.

    QC Ware and Roche explore biomedical image analysis

    A collaboration to explore quantum neural networks for biomedical image analysis.

    Quantinuum and Google search for quantum circuit optimization

    A collaboration between Quantinuum and Google DeepMind to explore AI-enhanced quantum circuit optimization.

    Google and Boehringer Ingelheim Pharmaceutical Research

    Exploring drug discovery and molecular modeling for future advantages in pharmaceutical development.

    Nord Quantique and Q-CTRL advance autonomous error correction

    Nord Quantique and Q-CTRL achieved a 14% increase in logical qubit lifetime through optimised autonomous quantum error correction.

    Xanadu and AstraZeneca explore drug discovery

    Exploring quantum computing for drug discovery and molecular simulation, aiming to accelerate new drug identification.

    1QBit explore drug discovery with Accenture and Biogen

    Accenture Labs and 1QBit work with Biogen to apply quantum computing to accelerate the research around drug discovery.

    CQC and Crown Bioscience explore drug discovery

    Exploring quantum computing for drug discovery and molecular simulation, demonstrating up to 100x speedup in specific molecular property calculations.

    Zapata and Biogen explore drug discovery with quantum machine learning

    Focusing on developing quantum-enhanced machine learning models for pharmaceutical research. This collaboration aimed to accelerate the identification of drug targets and optimize molecular properties using hybrid classical-quantum algorithms.

    CQC and Roche partner for drug discovery

    Applying quantum computing to drug discovery, Roche and CQC (now Quantinuum) aimed to reduce development timelines by 20-30% through advanced molecular simulation.

    QUARBONE's quantum-classical hybrid system explores carbon nanotube coprocessors

    The QUARBONE project, a collaboration between C12 Quantum Electronics, ATOS, and Artelys, aims to enhance industrial optimization through a quantum-classical hybrid system utilizing carbon nanotube coprocessors, achieving significant improvements in solution quality and computational efficiency across sectors like energy, logistics, chemistry, and finance.

    Industry Details

    No additional details available

    Target Roles

    Software Engineer
    Quantum Hardware Engineer
    Quantum Algorithm Developer
    Quantum Solutions Provider
    Quantum Cloud and Platform Provider
    Systems Integration Engineer
    Domain Expert
    Quantum Chemist